James Gornick - Comments
PMD Forensic Analyst with Investment Insights
Retired P.M.D. Forensic Analyst with Investment Insights in economics who created theorems being bantered about for the Austerity v. Coase Oppression Investing Demographic Winter. As a seasoned Medical Biopharma and trained Forensic Analyst in Economics, I specialize in developing and applying ...more
Latest Comments
Getting Past China’s Coronavirus
4 years ago

Was recently over the last hour, what do we see as INO real Price-TARGET’s over these next 6-14 Months?

We actually see the stock picking up new Analyst Upgrades with Updated Analysts Notes.

Most likely for Inovio INO may see their Share Prices jump as Regeneron had travelled when clearing the hurdles of locking in Proof of Concept.

We see their Price topping well over the $68 - $79 dollar a share just based on the HPV epidemic on met to this current discussion thread.

This doesn’t even include their other Pipeline Projects making great strides towards early Orphan Drug FDA approval.

Hopefully this answers those sending out to me their current questions addressing Inovio Pharmaceuticals in the near-term horizon of potential ROI

In this article: INO
31 to 31 of 31 comments
<<< 1 2 3 4